造血干细胞基因编辑挽救了B细胞在X结合性AGAMMAGLOBULINEMIA中的B细胞发育
Sameer Bahal1, Marta Zinicola1, Shefta E Moula1
1Infection, Immunity and Inflammation Research and Teaching Department, University College London Great Ormond Street Institute of Child Health, London, United Kingdom.
The Journal of allergy and clinical immunology
|March 13, 2024
概括
基因编辑成功地恢复了B细胞成熟和免疫球蛋白的产量在X结合性血红细胞瘤 (XLA) 模型. 这种方法为XLA提供了潜在的最终治疗方法,通过纠正血液造血干细胞中的布鲁顿氨酸激酶 (BTK) 基因缺陷.
科学领域:
- 免疫学 免疫学 免疫学
- 基因治疗 基因治疗
- 血液学 血液学 血液学
背景情况:
- 链接到X细胞的阿母球蛋白血症 (XLA) 是一种主要免疫缺陷,其特点是缺乏成熟的B细胞和免疫球蛋白,导致严重的感染.
- XLA是由布鲁顿氨酸激酶 (BTK) 基因的突变引起的,该基因对B细胞的发育和功能至关重要.
- 目前XLA的治疗方法通常是辅助的,这凸显了治疗策略的必要性.
研究的目的:
- 开发和评估一种基因编辑策略,用于纠正血造干细胞和前代细胞 (HSPCs) 中的BTK基因缺陷,用于XLA治疗.
- 评估基因编辑在恢复B细胞成熟和功能方面的有效性,无论是体外还是体内.
主要方法:
- 利用CRISPR-Cas9技术在患者衍生HSPC中诱导BTK位点的双链断裂.
- 使用腺相关病毒6 (AAV6) 提供治疗性BTK基因盒,用于同质导向修复.
- 在试验室中评估基因编辑效率和B细胞分化,并在免疫缺陷小鼠移植后评估B细胞复制和免疫球蛋白生产.
主要成果:
- 成功建立了一个体外B细胞分化模型来模仿XLA缺陷.
- 在已编辑的XLA HSPCs中证明了B细胞成熟的救援 in vitro.
- 在用基因编辑的XLA HSPC移植的小鼠中恢复了人类B细胞系和免疫球蛋白的产生.
结论:
- 在人类HSPC中实现了超过30%的基因编辑效率.
- 这项研究证明了基因编辑作为XLA的最终治疗方法的潜力.
- 这些发现表明,纠正细胞具有潜在的选择性优势,支持治疗策略.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K


